Biomedical Excellence for Safer Transfusion
  • Biomedical Excellence for Safer Transfusion (BEST)
    Biomedical Excellence for Safer Transfusion (BEST)

    BEST Collaborative is an international research organization with a vision to lead the field of transfusion medicine and cellular therapies toward the best…

  • BEST Membership
    BEST Membership

    The BEST collaborative is a unique free-standing group of over 170 manufacturers, clinicians, and scientists from 22 countries committed to improving transfusion…

  • BEST Meetings
    BEST Meetings

    BEST meetings are held twice per year. and attendance is open to all members. Invited guests may attend with pre-approval of the Chair.

  • Press Releases
    Press Releases

    Official notices regarding significant publications, special events, and member news.

  • Recommended Procedures
    Recommended Procedures

    Several best practice documents are available for download

  • Sponsorship
    Sponsorship

    Any commercial organization or Blood Service interested in advancing the purpose of BEST may become a supporter of BEST by paying the annual dues amount; providing a…

Latest News

Press Release 24 Aug 2020

Award Recipient of 25th Scott Murphy Memorial Award Lectureship Announced

Press Release 21 May 2020

Award Recipient of 24th Scott Murphy Memorial Award Lectureship Announced

Press Release 28 Aug 2019

Award Recipient of 23rd Scott Murphy Memorial Award Lectureship Announced

Member Reminders

  • BEST LX Virtual Main Meeting was held 30 Oct-06 Nov 2020. All meeting sessions have been recorded for those who are unable to attend and will be posted in the members area in the coming weeks.
  • Tentative arrangements have been made with the Bristol Hotel to hold the Warsaw Meeting in Spring 2022. The Spring 2021 meeting will be held virtually.
  • Members who wish to invite MEETING and/or CONFERENCE CALL guests must have the pre-approval of the Chair. Please submit your requests for approval well in advance of each event. Approved guests will receive a separate Registration & Dinner RSVP, as well as meeting materials, and must complete a Non-Disclosure Agreement (NDA). This applies to the Virtual Meeting as well.
  • Please be sure to keep your contact information on the website up to date so you can be assured of receiving our email updates.
 

Fall 2020

Washington DC

BEST LX Virtual Meeting

  • The Executive Committee agreed to move to a completely virtual platform.
  • The date for the main virtual meeting is Friday, November 6, 2020.
  • Individual team meetings are being held from Oct 30 to Nov 5.
  • Advance registrations are required for all sessions.
  • Guests must be approved in advance by the Chair.

 

Spring 2021

Warsaw

BEST LXI Meeting

The Spring 2021 Meeting will be held virtually

Important News

  • Please read the previous email communications regarding the cancellation of the face-to-face April 2021 meeting
  • Due to the continuing COVID-19 pandemic, we have rescheduled the Warsaw Meeting for 2022.
  • Dates for both events are to be determined.

 

A A A

BEST Collaborative is an international research organization with a vision to lead the field of transfusion medicine and cellular therapies toward the best products and practices for donors and patients.

We have 42 scientific members, 15 manufacturing sponsors, and 22 blood service sponsors from 22 countries representing a diversity of interests and high levels of accomplishment. The supporting members of BEST span a broad range of the companies and blood suppliers engaged with blood collection, distribution and transfusion worldwide. We also have been pleased to have some participation from regulatory agencies such as FDA and the Paul Ehrlich Institute. BEST has published 135 peer reviewed papers and has 40 studies currently open. As part of our mission, BEST believes it brings to the community thoughtful consideration to identify important questions in Transfusion Medicine, design and execute studies to address these questions, and provide critical thought and synthesis of the available evidence.